[go: up one dir, main page]

DE69625354D1 - RELAXIN-LIKE FACTOR AND RELATED METHODS AND USE - Google Patents

RELAXIN-LIKE FACTOR AND RELATED METHODS AND USE

Info

Publication number
DE69625354D1
DE69625354D1 DE69625354T DE69625354T DE69625354D1 DE 69625354 D1 DE69625354 D1 DE 69625354D1 DE 69625354 T DE69625354 T DE 69625354T DE 69625354 T DE69625354 T DE 69625354T DE 69625354 D1 DE69625354 D1 DE 69625354D1
Authority
DE
Germany
Prior art keywords
relaxin
factor
related methods
analogs
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69625354T
Other languages
German (de)
Other versions
DE69625354T2 (en
Inventor
Christian Schwabe
Elaine Unemori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of South Carolina
Medical University of South Carolina MUSC
Connective Therapeutics Inc
Original Assignee
University of South Carolina
Medical University of South Carolina MUSC
Connective Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of South Carolina, Medical University of South Carolina MUSC, Connective Therapeutics Inc filed Critical University of South Carolina
Publication of DE69625354D1 publication Critical patent/DE69625354D1/en
Application granted granted Critical
Publication of DE69625354T2 publication Critical patent/DE69625354T2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a relaxin-like factor, its derivatives or analogs, and uses thereof. The present invention further relates to compositions comprising a relaxin-like factor, its derivatives or analogs, and relaxin wherein such composition exhibits an additive or synergistic effect.
DE69625354T 1995-06-07 1996-05-16 RELAXIN-LIKE FACTOR AND RELATED METHODS AND USE Expired - Lifetime DE69625354T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/484,219 US5911997A (en) 1995-06-07 1995-06-07 Relaxin-like factor and methods and uses thereof
PCT/US1996/007399 WO1996040186A1 (en) 1995-06-07 1996-05-16 Relaxin-like factor and methods and uses thereof

Publications (2)

Publication Number Publication Date
DE69625354D1 true DE69625354D1 (en) 2003-01-23
DE69625354T2 DE69625354T2 (en) 2003-10-30

Family

ID=23923245

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69625354T Expired - Lifetime DE69625354T2 (en) 1995-06-07 1996-05-16 RELAXIN-LIKE FACTOR AND RELATED METHODS AND USE

Country Status (9)

Country Link
US (2) US5911997A (en)
EP (1) EP0831871B1 (en)
JP (1) JP3830520B2 (en)
AT (1) ATE229340T1 (en)
AU (1) AU709115B2 (en)
CA (1) CA2224080C (en)
DE (1) DE69625354T2 (en)
ES (1) ES2188763T3 (en)
WO (1) WO1996040186A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2229479C (en) 1995-08-15 2010-03-30 Connective Therapeutics, Inc. Method of promoting angiogenesis
DE19641378C1 (en) * 1996-09-27 1998-04-02 Ihf Inst Fuer Hormon Und Fortp Diagnostic aids and procedures to prove the pregnancy of ruminants
GB9717652D0 (en) * 1997-08-20 1997-10-22 Nycomed Imaging As Method
AUPR814401A0 (en) 2001-10-08 2001-11-01 Howard Florey Institute Of Experimental Physiology And Medicine Human 3 relaxin
US20050186526A1 (en) * 2002-11-01 2005-08-25 Bas Medical, Inc. Methods and systems for enabling and stabilizing tooth movement
AU2003903124A0 (en) * 2003-06-20 2003-07-10 Mark Del Borgo Analogues of heteromeric proteins
US7878978B2 (en) * 2004-03-18 2011-02-01 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
JP4836942B2 (en) * 2004-04-30 2011-12-14 コーセラ， インコーポレイテッド Methods and compositions for the control of fetal development by modulation of relaxin
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
EP1984016A1 (en) * 2006-02-17 2008-10-29 Associazione Foresta Per La Ricerca Nella Riproduzione Umana Use of insulin-like factor 3 for treating osteoporosis and bone disorders
JP5727938B2 (en) * 2008-11-24 2015-06-03 コーセラ，インコーポレーテッド How to test the high risk of developing pre-eclampsia
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
SI3572091T1 (en) 2010-08-17 2024-07-31 Ambrx, Inc., Modified relaxin polypeptides and their uses
US9434780B2 (en) * 2011-08-04 2016-09-06 Relaxera Pharma Gmbh & Co. Kg I.G. Process for preparing human relaxin-2
WO2013177529A1 (en) * 2012-05-24 2013-11-28 Angion Biomedica Corp. Relaxin-like compounds and uses thereof
US9393288B2 (en) 2012-05-29 2016-07-19 The University Of Vermont And State Agricultural College Methods of treating diseases associated with PPARγ
WO2014040008A1 (en) * 2012-09-10 2014-03-13 Angion Biomedica Corp. Relaxin-like peptides and uses thereof
KR102302634B1 (en) 2013-09-13 2021-09-14 더 스크립스 리서치 인스티튜트 Modified therapeutic agents and compositions thereof
EP4212180A1 (en) 2013-12-18 2023-07-19 The Scripps Research Institute Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
MA41794A (en) * 2015-03-18 2018-01-23 The California Institute For Biomedical Res MODIFIED THERAPEUTIC AGENTS AND ASSOCIATED COMPOSITIONS
EP3387019B1 (en) 2015-12-09 2021-10-20 The Scripps Research Institute Relaxin immunoglobulin fusion proteins and methods of use
BR112019016139A2 (en) 2017-02-08 2020-04-07 Bristol-Myers Squibb Company modified relaxin polypeptide comprising a pharmacokinetic enhancer and uses thereof
KR20240032010A (en) 2021-06-09 2024-03-08 더 스크립스 리서치 인스티튜트 Long-acting dual GIP/GLP-1 peptide conjugate and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0101309B1 (en) * 1982-08-12 1991-01-16 Howard Florey Institute Of Experimental Physiology And Medicine Molecular cloning and characterization of a gene sequence coding for human relaxin
US4835251A (en) * 1986-06-23 1989-05-30 Genetech, Inc. Method of chain combination
US5478807A (en) * 1991-08-19 1995-12-26 Genentech, Inc. Use of relaxin in the treatment of bradycardia
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy

Also Published As

Publication number Publication date
JPH11512072A (en) 1999-10-19
WO1996040186A1 (en) 1996-12-19
AU5869996A (en) 1996-12-30
EP0831871A4 (en) 1999-03-03
EP0831871B1 (en) 2002-12-11
CA2224080C (en) 2010-07-27
DE69625354T2 (en) 2003-10-30
AU709115B2 (en) 1999-08-19
US5911997A (en) 1999-06-15
EP0831871A1 (en) 1998-04-01
US20030158376A1 (en) 2003-08-21
ES2188763T3 (en) 2003-07-01
JP3830520B2 (en) 2006-10-04
ATE229340T1 (en) 2002-12-15
CA2224080A1 (en) 1996-12-19
US6949506B2 (en) 2005-09-27

Similar Documents

Publication Publication Date Title
DE69625354D1 (en) RELAXIN-LIKE FACTOR AND RELATED METHODS AND USE
DE69424517D1 (en) Gas generating compositions
ATE225341T1 (en) PACLITAXELE SUBSTITUTED BY THIO IN 6 POSITION
FI20010060A7 (en) 5-methoxyindole-3-carboxyaldehydeamino-(pentylamino)methylenehydrazone
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
MX9203396A (en) MOMETASONE FUROATE MONOHYDRATE, PROCESS TO PRODUCE IT AND PHARMACEUTICAL COMPOSITIONS.
MX9202496A (en) MIXED COATING COMPOSITIONS.
BG102259A (en) Compostions with controlled paroxetine release
DE69103720D1 (en) Primer composition for gas inflator.
DK1144472T3 (en) Aqueous reactive putties (II)
MX9804588A (en) Use of halogen bleach-comprising compositions for improved mildness to the skin.
MA24643A1 (en) SUBSTITUTED TETRAHYDRO-NAPHTHALENES AND SIMILAR COMPOUNDS
ES2181744T3 (en) HYDRAPTS OF PACLITAXEL CRISTALINOS.
DE69421784D1 (en) Fuel compositions, and additives therefor
BG99177A (en) NEW 7 BETA-SUBSTITUTED-4-AZA-5 ALPHA-CHOLESTANONE AS 5 ALPHA REDUCTASE INHIBITORS
IL109720A (en) N-alkylthio polyamine derivatives and radioprotective compositions containing them
SI1086096T1 (en) Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
DE68920622D1 (en) Polyketone compositions.
EA199800534A1 (en) APPLICATION OF 2-ETHYLHEXYL-α-CYANO-β, β-DIPHENYLACRIATE
BG100248A (en) SQUALENSENTEZA INHIBITORS
DE69428315D1 (en) Moisture-curing polysiloxane coating compositions
DK0977871T3 (en) Neurotrypsin
ITRM940126A0 (en) ADDITIVE FOR CEMENT COMPOSITIONS. (CASE 154-0241)
MX9602836A (en) MIXTURE CONTAINING ONE OR SEVERAL ALPHA-AMINO ACIDS AND THEIR DERIVATIVES, OR BOTH, AND ONE OR MANY CYCLOPENTANE- beta-AMINO ACIDS AND THEIR DERIVATIVES, OR BOTH.
MX9603199A (en) Endotheline receptors antagonists.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition